FRK plays an oncogenic role in non‐small cell lung cancer by enhancing the stemness phenotype via induction of metabolic reprogramming-Reference-Cited by-同舟云学术

FRK plays an oncogenic role in non‐small cell lung cancer by enhancing the stemness phenotype via induction of metabolic reprogramming

Published:2019-07-26 Issue:1 Volume:146 Page:208-222
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Zhang Li¹,Yang Yongfeng¹,Chai Li²,Bu Hong¹,Yang Ying³,Huang Hong¹,Ran Jingjing¹,Zhu Yihan¹,Li Li¹,Chen Fei¹,Li Weimin⁴^ORCID

Affiliation:

1. Lab of Pathology, Key Lab of Transplantation Engineering and Immunology, Ministry of Health, Precision Medicine Key Laboratory of Sichuan ProvinceWest China Hospital, Sichuan University Chengdu Sichuan Province China

2. Research Core FacilityWest China Hospital, Sichuan University Chengdu Sichuan Province China

3. Center of Precision Medicine, Precision Medicine Key Laboratory of Sichuan ProvinceWest China Hospital, Sichuan University Chengdu Sichuan Province China

4. Department of Respiratory Medicine, Precision Medicine Key Laboratory of Sichuan ProvinceWest China Hospital, Sichuan University Chengdu Sichuan Province China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32530

Reference40 articles.

1. Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology

2. Cloning of FRK, a novel human intracellular SRC-like tyrosine kinaseencoding gene

3. Rak Functions as a Tumor Suppressor by Regulating PTEN Protein Stability and Function